Autor:	Samuel Adediran, Shereen M F Gheith Md, Usman Shah, Ben Fisher, Pal Singh-Kahlon
Rok vydání:	2018
Předmět:	Cancer Research Her2 expression Oncology business.industry Point mutation Cancer research Medicine Small bowel adenocarcinoma business
Zdroj:	Journal of Clinical Oncology. 36:e16261-e16261
ISSN:	1527-7755 0732-183X
DOI:	10.1200/jco.2018.36.15_suppl.e16261
Popis:	e16261Background: The frequency of HER2 alterations in SBA varies widely in the literature but overall reported as point mutations in 9.5-12% of SBA and amplification in < 5% of SBA. Given the role...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::4df55aeea8a94a4b2a77a18ae810c301 https://doi.org/10.1200/jco.2018.36.15_suppl.e16261 Zobrazit plný text záznamu